Metabolic changes related to the IDH1 mutation in gliomas preserve TCA‐cycle activity: An investigation at the protein level. Issue 3 (20th January 2020)

• Record Type: Journal Article
• Authors: Dekker, Lennard J. M.; Wu, Suying; Jurriëns, Cherise; Mustafa, Dana A. N.; Grevers, Frederieke; Burgers, Peter C.; Sillevis Smitt, Peter A. E.; Kros, Johan M.; Luider, Theo M.
• Is Part Of: FASEB journal. Volume 34:Issue 3(2020)
• Page Start: 3646
• Page End: 3657
• Publication Date: 2020-01-20
• Subjects: glioma -- glutaminolysis -- IDH1 mutation -- metabolism -- proteomics -- TCA cycle; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201902352R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: The discovery of the IDH1 R132H (IDH1 mut) mutation in low‐grade glioma and the associated change in function of the IDH1 enzyme has increased the interest in glioma metabolism. In an earlier study, we found that changes in expression of genes involved in the aerobic glycolysis and the TCA cycle are associated with IDH1 mut. Here, we apply proteomics to FFPE samples of diffuse gliomas with or without IDH1 mutations, to map changes in protein levels associated with this mutation. We observed significant changes in the enzyme abundance associated with aerobic glycolysis, glutamate metabolism, and the TCA cycle in IDH1 mut gliomas. Specifically, the enzymes involved in the metabolism of glutamate, lactate, and enzymes involved in the conversion of α‐ketoglutarate were increased in IDH1 mut gliomas. In addition, the bicarbonate transporter (SLC4A4) was increased in IDH1 mut gliomas, supporting the idea that a mechanism preventing intracellular acidification is active. We also found that enzymes that convert proline, valine, leucine, and isoleucine into glutamate were increased in IDH1 mut glioma. We conclude that in IDH1 mut glioma metabolism is rewired (increased input of lactate and glutamate) to preserve TCA‐cycle activity in IDH1 mut gliomas.